BioFinlandin jäsen

Helsinki Innovation Services Ltd (HIS) is a fully owned subsidiary of the University of Helsinki Funds, managing all innovation related matters at the University of Helsinki, including liaison with academics, asset evaluation, intellectual property protection and commercialisation activities. HIS has a strong Life Science portfolio with assets in pharmaceutical discovery and development, diagnostics, biomarkers and medical device fields. We are actively seeking out-licensing opportunities, as well as investors and experienced management teams to support spin-out formation.